BRIEF-Incyte and Agenus amend collaboration agreement
February 14, 2017 at 07:16 AM EST
* Incyte Corp - amended agreement converts ongoing GITR and ox40 antibody programs from co-funded development and profit-sharing arrangements to royalty-bearing programs